RYDE GROUP LTD-A (RYDE)

KYG7733R1020 - Common Stock

1.58  -0.34 (-17.71%)

Premarket: 1.55 -0.03 (-1.9%)

Fundamental Rating

1

Overall RYDE gets a fundamental rating of 1 out of 10. We evaluated RYDE against 37 industry peers in the Ground Transportation industry. RYDE may be in some trouble as it scores bad on both profitability and health. RYDE has a expensive valuation and it also scores bad on growth.



0

1. Profitability

1.1 Basic Checks

RYDE had negative earnings in the past year.
In the past year RYDE has reported a negative cash flow from operations.

1.2 Ratios

RYDE's Return On Assets of -246.82% is on the low side compared to the rest of the industry. RYDE is outperformed by 97.22% of its industry peers.
Industry RankSector Rank
ROA -246.82%
ROE N/A
ROIC N/A
ROA(3y)-131.35%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

RYDE's Gross Margin of 21.39% is on the low side compared to the rest of the industry. RYDE is outperformed by 69.44% of its industry peers.
RYDE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

RYDE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RYDE has less shares outstanding
The debt/assets ratio for RYDE has been reduced compared to a year ago.

2.2 Solvency

RYDE has an Altman-Z score of -12.28. This is a bad value and indicates that RYDE is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of RYDE (-12.28) is worse than 94.44% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -12.28
ROIC/WACCN/A
WACC7.83%

2.3 Liquidity

A Current Ratio of 0.35 indicates that RYDE may have some problems paying its short term obligations.
RYDE has a Current ratio of 0.35. This is amonst the worse of the industry: RYDE underperforms 94.44% of its industry peers.
A Quick Ratio of 0.35 indicates that RYDE may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.35, RYDE is doing worse than 94.44% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.35

3

3. Growth

3.1 Past

RYDE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -160.55%.
The Revenue has decreased by -1.79% in the past year.
EPS 1Y (TTM)-160.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-160.55%
Revenue 1Y (TTM)-1.79%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-1.79%

3.2 Future

RYDE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 36.46% yearly.
Based on estimates for the next years, RYDE will show a very strong growth in Revenue. The Revenue will grow by 32.57% on average per year.
EPS Next Y72.45%
EPS Next 2Y36.46%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year35.76%
Revenue Next 2Y32.57%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RYDE. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RYDE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

RYDE's earnings are expected to grow with 36.46% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.46%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for RYDE!.
Industry RankSector Rank
Dividend Yield N/A

RYDE GROUP LTD-A

NYSEARCA:RYDE (9/16/2024, 8:04:00 PM)

Premarket: 1.55 -0.03 (-1.9%)

1.58

-0.34 (-17.71%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryGround Transportation
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap32.99M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -246.82%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 21.39%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.67
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.35
Quick Ratio 0.35
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-160.55%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y72.45%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-1.79%
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y